"The support from the FDA to date is being seriously overlooked IMO. They dont just hand this stuff out to anyone", @moguns, I think you are right on the money.
Based on company's announcement " New Antimicrobial Data and Conference Presentation" dated 08/09/2020, page 3 - "shows that treatment with synthetic cannabidiol resulted in disruption of the bacterial membrane (allowing the green dye to permeate the cytoplasmic membrane of Staph) resulting in cell death and prevention of bacterial growth and multiplication. Conversely, the negative control shows that without the presence of CBD, the bacterial membrane remained intact (preventing the dye from crossing the cytoplasmic membrane), allowing the Staph to grow and multiply
Ann: FDA Clears Development Path for BTX 1801, page-75
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 36.0¢ | 34.5¢ | $1.255M | 3.601M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 206282 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 316320 | 5 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |